Culture-free bacterial detection and identification
Culture-Free Bacterial Detection and Identification from Blood with Rapid, Phenotypic Antibiotic Susceptibility Testing
1. Understanding Bloodstream Infections and the Need for Rapid Diagnosis
Bloodstream infections (BSIs) are serious medical conditions characterized by the presence of pathogenic microorganisms in the bloodstream. They can result from bacterial invasion through damaged skin barriers, infected tissues, medical devices, or other infectious sources. Once bacteria enter the circulation, they can trigger systemic inflammatory responses and potentially lead to severe complications, including sepsis, organ dysfunction, and life-threatening conditions.
The rapid identification of bacterial pathogens responsible for bloodstream infections is essential for initiating appropriate antimicrobial treatment. However, conventional diagnostic approaches rely primarily on blood culture techniques, which often require substantial time before providing definitive information about the causative microorganism and its susceptibility to antibiotics.
The current culture-based approach for diagnosing bloodstream infections is increasingly considered insufficient for situations requiring immediate therapeutic decisions. One of its main limitations is the long time-to-result, which can delay targeted antimicrobial treatment and complicate efforts to control the spread of multidrug-resistant organisms (MDROs).
Bloodstream infections frequently involve extremely low bacterial concentrations. In some cases, bacterial levels may be below 10 colony-forming units (CFU) per millilitre of blood. Detecting such low microbial concentrations through conventional culture techniques requires sensitive methods, specialized laboratory procedures, and considerable incubation time.
The detection process may take as long as 72 hours when the complete diagnostic workflow, including identification and antibiotic susceptibility testing, is considered.
Consequently, researchers have increasingly focused on developing rapid diagnostic technologies capable of detecting bacterial pathogens directly from blood samples without requiring conventional culture enrichment.
These approaches aim to accelerate pathogen identification, provide information about antibiotic susceptibility, and support more appropriate antimicrobial treatment decisions.
2. Limitations of Conventional Blood Culture Methods
Blood culture remains an important approach in clinical microbiology for detecting viable microorganisms responsible for bloodstream infections. The conventional workflow generally involves collecting blood samples, inoculating culture bottles, incubating the samples, and subsequently identifying the microorganisms that demonstrate detectable growth.
Once bacterial growth has been detected, additional laboratory procedures are required to isolate the pathogen and determine its identity. Antibiotic susceptibility testing is then performed to evaluate the response of the isolated microorganism to different antimicrobial agents.
Although this approach provides valuable microbiological information, several limitations can affect its performance and clinical usefulness.
2.1. Long Diagnostic Turnaround Time
One of the most important disadvantages of conventional blood culture is the time required to obtain results.
Depending on the microorganism and the laboratory workflow, blood cultures typically require approximately 24 to more than 48 hours to provide an initial result.
After bacterial isolation, antibiotic susceptibility testing generally requires an additional 16–24 hours of incubation to evaluate bacterial growth in the presence of antimicrobial agents.
This sequential diagnostic process can considerably delay the identification of an effective antibiotic treatment.
During this period, clinicians frequently need to initiate empirical broad-spectrum antibiotic therapy because the responsible pathogen and its susceptibility profile are not yet known.
Although empirical treatment can be essential in managing suspected severe infections, prolonged exposure to inappropriate or unnecessarily broad antimicrobial agents may contribute to adverse drug effects, disruption of normal microbiota, opportunistic infections, and the selection of antibiotic-resistant microorganisms.
2.2. Extremely Low Bacterial Concentrations in Blood
Another major limitation of conventional blood culture is the low concentration of bacteria frequently encountered in bloodstream infections.
In certain patients, bacterial concentrations may fall below 10 CFU/mL, making microbial detection particularly challenging.
When the number of viable bacteria in a blood sample is extremely low, sufficient time may be required before microorganisms multiply to detectable levels.
Consequently, conventional cultures may produce delayed results or even remain negative despite the presence of an infection.
This problem is particularly relevant when investigating infections associated with medical devices, including central line-associated bloodstream infections and prosthetic valve endocarditis.
Some microorganisms may also fail to grow under standard culture conditions because they require specific nutritional components, atmospheric conditions, or environmental factors.
These limitations can reduce the sensitivity of conventional blood culture procedures and complicate the diagnosis of certain bloodstream infections.
2.3. Culture-Negative Bloodstream Infections
Culture-negative infections represent an important diagnostic challenge.
In these situations, clinical and laboratory findings may indicate an infection even though conventional blood cultures do not successfully recover the responsible microorganism.
The original study highlights that up to 30% of prosthetic valve endocarditis cases may initially be culture-negative.
Several factors can contribute to negative blood culture results, including low bacterial concentrations, previous antimicrobial exposure, inadequate sample conditions, and the presence of microorganisms that are difficult to cultivate.
These challenges demonstrate the importance of developing alternative diagnostic methods capable of detecting bacterial pathogens without depending entirely on conventional microbial growth.
2.4. Contamination During Blood Sample Collection
Blood culture contamination is another important limitation of conventional microbiological diagnosis.
During sample collection, microorganisms normally present on the surface of the skin can accidentally enter the blood culture bottle.
These contaminants may subsequently multiply in the culture medium and complicate the interpretation of laboratory results.
Certain skin-associated microorganisms can grow rapidly and potentially interfere with the detection of the actual pathogen.
When contamination is suspected, additional blood cultures may be necessary to distinguish genuine bloodstream infection from the presence of microorganisms introduced during sample collection.
This additional testing increases diagnostic turnaround time and can complicate clinical decision-making.
3. Multidrug-Resistant Organisms and the Importance of Rapid Antibiotic Susceptibility Testing
Antimicrobial resistance represents a major challenge in modern healthcare and infectious disease management.
Multidrug-resistant organisms are microorganisms that have developed resistance to multiple antimicrobial agents, making conventional treatment strategies less effective.
The increasing prevalence of MDROs highlights the importance of identifying bacterial pathogens and determining their antibiotic susceptibility as rapidly as possible.
When the responsible microorganism is unknown, patients with suspected bloodstream infections may receive broad-spectrum antibiotics that target a wide range of bacterial pathogens.
Although this approach provides initial antimicrobial coverage, it does not always correspond to the actual susceptibility profile of the infecting organism.
The excessive or inappropriate use of antibiotics can promote the selection of resistant microorganisms and contribute to changes in the composition of normal microbial communities.
Rapid antibiotic susceptibility testing (AST) can help address this challenge by providing information about the response of bacterial pathogens to specific antimicrobial agents.
Instead of relying exclusively on bacterial identification, AST evaluates whether a microorganism is inhibited or continues to grow when exposed to an antibiotic.
This information is essential for distinguishing susceptible, intermediate, and resistant bacterial responses according to the criteria used by the validated test system.
The development of rapid phenotypic AST technologies therefore represents an important direction in clinical microbiology.
4. Culture-Free Bacterial Detection: An Alternative Diagnostic Approach
Culture-free bacterial detection aims to identify microorganisms directly from biological samples without requiring conventional culture-based enrichment before the detection step.
This approach has attracted considerable interest because it can reduce the time required to detect bacterial pathogens and provide information that would otherwise require several sequential laboratory procedures.
Traditional culture-dependent methods rely on the multiplication of microorganisms until their concentrations become sufficiently high for detection.
In contrast, culture-free diagnostic platforms use analytical technologies capable of identifying bacterial targets directly within the original sample.
These technologies may involve immunological recognition, molecular detection, biosensors, electrochemical measurements, or other signal-amplification mechanisms.
For bloodstream infections, direct detection is particularly challenging because bacterial concentrations can be extremely low compared with the large quantity of human cells and other biological components present in whole blood.
The detection system must therefore provide sufficient analytical sensitivity while minimizing background signals and interference from the sample matrix.
4.1. Immunological Detection of Bacterial Pathogens
Immunological detection methods rely on the specific interaction between antibodies and bacterial surface antigens or other molecular targets.
Antibodies are proteins capable of recognizing particular molecular structures, making them valuable tools for detecting microorganisms in complex biological samples.
In an immunoassay-based detection platform, specific antibodies capture the bacterial target and generate a measurable signal through a suitable detection system.
The use of selective antibody recognition provides an opportunity to combine bacterial detection with identification.
Unlike approaches that simply measure the presence of bacterial genetic material, antibody-based detection can provide information about the identity of microorganisms recognized by the selected antibodies.
However, detection specificity depends on the characteristics of the antibodies and the bacterial targets included in the platform.
4.2. Signal Amplification for Ultrasensitive Detection
Detecting bacteria present at concentrations below 10 CFU/mL requires highly sensitive analytical methods.
One strategy is to combine specific immunological recognition with an amplification mechanism that increases the measurable signal generated by the detection reaction.
Signal amplification improves the ability of an analytical platform to distinguish low concentrations of target microorganisms from background signals.
In the research described in the original study, an immunodetection platform incorporating intrinsic signal-current amplification was developed to improve the detection of bacteria directly from blood samples.
The method uses field effect enzymatic detection (FEED), which combines an enzymatic detection system with an electrically controlled signal-amplification mechanism.
This approach allows the detection platform to identify very low concentrations of bacteria without requiring conventional culture enrichment before analysis.
5. Field Effect Enzymatic Detection (FEED) Technology
Field effect enzymatic detection, commonly abbreviated as FEED, is the analytical technology used in the investigated culture-free diagnostic platform.
The system combines immunological recognition, enzymatic signal generation, and electrical amplification to improve the sensitivity of bacterial detection.
A central component of the platform is an electrochemical detection system containing a working electrode and an enzyme-based detection complex.
Horseradish peroxidase (HRP), a redox-active enzyme, is immobilized on the working electrode through a sandwich immunocomplex involving specific antibodies and the bacterial target.
The detection process is based on the ability of the enzymatic component to generate an electrochemical signal that can be amplified through an externally applied gating voltage.
5.1. Role of Horseradish Peroxidase
Horseradish peroxidase is an enzyme frequently used in immunoassays and biochemical detection systems.
It can catalyze oxidation-reduction reactions involving suitable substrates, producing measurable electrochemical or optical signals depending on the detection configuration.
In the FEED platform, HRP serves as an enzymatic component associated with the immunological detection complex.
Its presence on the working electrode allows the enzymatic reaction to generate an electrical signal that can be monitored during the measurement process.
5.2. Sandwich Immunoassay Formation
The bacterial detection mechanism uses an antibody-mediated sandwich structure.
Specific antibodies interact with bacterial targets, allowing the microorganism to become associated with the detection system.
The sandwich immunocomplex connects the bacterial recognition process with the enzyme-labelled detection component.
This arrangement provides the molecular specificity required for distinguishing the target bacterium from other components present in the blood sample.
The resulting HRP-associated signal is then measured by the electrochemical system.
5.3. Voltage-Controlled Signal Amplification
An important characteristic of the FEED platform is its ability to amplify the electrical signal through an applied gating voltage.
A voltage is applied between the gating electrode and the working electrode, generating an electric field at the solution-enzyme-electrode interface.
This electric field reduces the electron tunnelling barrier, facilitating the transfer of electrons between the electrode and the HRP-associated detection complex.
As a result, the measured tunnel current is amplified.
By increasing the amplitude of the enzymatic signal, the platform can detect bacterial concentrations that would otherwise generate signals too weak for conventional measurements.
This signal-amplification principle supports the direct detection of extremely low bacterial concentrations in blood samples.
6. Rapid Bacterial Detection and Identification from Blood
The culture-free platform was designed to combine bacterial detection and identification within a single analytical workflow.
In the original experimental investigation, the system demonstrated the ability to detect Escherichia coli directly from blood samples at concentrations below 10 CFU/mL without conventional culture enrichment.
The reported detection and identification time was approximately 84 minutes from sample to result.
This represents an important reduction compared with conventional blood culture workflows, which typically require substantially longer incubation periods.
The platform relies on specific immunological recognition between bacterial targets and antibodies.
Consequently, the detection signal provides information about the presence of the targeted bacterium, allowing bacterial detection and identification to be achieved simultaneously.
This is particularly relevant when working with complex biological samples in which several microbial populations may potentially be present.
Quantitative Detection of Low Bacterial Concentrations
The ability to detect bacteria at very low concentrations is an important characteristic of the FEED-based approach.
Signal amplification allows the detection platform to measure small changes in enzymatic activity associated with the presence of bacterial targets.
In the study, E. coli was detected at concentrations below 10 CFU/mL without performing prior culture enrichment.
This finding demonstrates the potential of combining antibody-based bacterial recognition with electrically amplified enzymatic detection.
The quantitative nature of the signal also provides opportunities for monitoring changes in bacterial concentrations over time.
7. Rapid Phenotypic Antibiotic Susceptibility Testing
In addition to bacterial detection and identification, the investigated platform was designed to perform rapid antibiotic susceptibility testing.
Phenotypic AST evaluates the actual response of bacteria to antimicrobial exposure rather than relying exclusively on the presence or absence of specific resistance genes.
This distinction is important because bacterial resistance may involve different molecular mechanisms, and the detection of a genetic marker does not always establish the complete phenotypic response of an organism to a particular antibiotic.
Traditional phenotypic susceptibility testing requires bacterial isolation followed by additional incubation in the presence of antimicrobial compounds.
The time needed to obtain sufficient bacterial growth can make this process relatively slow.
The FEED platform addresses this limitation by monitoring short-term bacterial growth directly in blood over approximately one to two hours.
7.1. Monitoring Bacterial Growth in the Presence of Antibiotics
The ability to detect bacteria at very low concentrations makes it possible to monitor changes in bacterial populations over relatively short periods.
When bacteria are exposed to an antibiotic, their growth and viability may be affected depending on their susceptibility to the antimicrobial agent.
By monitoring changes in the detection signal over time, researchers can investigate the bacterial response following antibiotic exposure.
In the reported study, this principle was used to perform rapid susceptibility testing involving susceptible and resistant strains of Escherichia coli exposed to ampicillin.
The system demonstrated that changes in the enzymatic detection signal could provide information about bacterial responses to antimicrobial treatment.
7.2. Differentiating Susceptible, Intermediate and Resistant Responses
One of the important features demonstrated by the experimental platform was its ability to distinguish susceptible, intermediate, and resistant antibiotic responses.
These categories provide information about how bacterial isolates respond to specific antimicrobial agents under defined experimental conditions.
Susceptible (S): A susceptible bacterial population demonstrates inhibition at antibiotic exposures corresponding to the applicable susceptibility criteria.
Intermediate (I): An intermediate response indicates that the bacterial response falls within an intermediate interpretation category according to the applicable testing criteria.
Resistant (R): A resistant bacterial population continues to demonstrate growth or viability under antibiotic exposure conditions that would be expected to inhibit susceptible organisms.
The distinction between these responses is particularly important in antimicrobial research because it provides information that can support the selection of appropriate therapeutic strategies.
The rapid phenotypic approach described in the study provides quantitative information about bacterial responses and helps differentiate bacteriostatic and bactericidal effects.
7.3. Distinguishing Bacteriostatic and Bactericidal Effects
Antibiotics can affect bacterial populations through different mechanisms.
Bacteriostatic agents primarily inhibit bacterial multiplication, preventing or slowing population growth.
Bactericidal agents produce a reduction in bacterial viability by killing susceptible bacteria.
These different responses are important when evaluating the effects of antimicrobial compounds and interpreting changes in bacterial populations following exposure.
Monitoring bacterial growth over short time periods can provide valuable information about how microorganisms respond to antibiotic treatment.
By evaluating variations in the detection signal, the FEED-based system provides an approach for investigating antimicrobial activity without requiring the full duration of conventional culture-based susceptibility testing.
8. Conventional Culture-Based AST Compared with Culture-Free Phenotypic Detection
Traditional blood culture and rapid culture-free phenotypic testing use different analytical principles and workflows.
Conventional methods depend on bacterial multiplication to produce detectable cultures, followed by pathogen identification and additional susceptibility testing.
Culture-free platforms seek to detect bacterial targets directly and evaluate their response to antibiotics through alternative signal-detection mechanisms.
| Characteristic | Conventional blood culture | Culture-free FEED approach |
|---|---|---|
| Initial bacterial detection | Microbial growth in culture media | Direct immunological detection |
| Culture enrichment | Required | Not required before detection |
| Identification | Usually performed after bacterial growth | Integrated with antibody-based detection |
| Low bacterial concentrations | May require extended incubation | Demonstrated below 10 CFU/mL in the study |
| Detection and identification time | Typically 24–48 hours or longer | Approximately 84 minutes in the reported experiment |
| Antibiotic susceptibility testing | Additional incubation after isolation | Short-term phenotypic monitoring |
| Reported AST time | Commonly 16–24 additional hours | Approximately 204 minutes in the reported experiment |
The comparison highlights the potential advantages of rapid, culture-free approaches while emphasizing the importance of validating their performance for different microorganisms and clinical sample types.
9. Advantages of Culture-Free Bacterial Detection Technologies
The development of culture-free diagnostic platforms introduces several potential advantages for microbiological research and bloodstream infection diagnosis.
Reduced Time-to-Result: Direct detection can eliminate the need for prolonged preliminary culture enrichment and accelerate the availability of bacterial identification information.
Detection of Low Bacterial Concentrations: Highly sensitive signal-amplification systems can facilitate the detection of microorganisms present at very low concentrations.
Simultaneous Detection and Identification: Antibody-based recognition can provide information about both bacterial presence and identity within the same analytical approach.
Rapid Phenotypic Antibiotic Susceptibility Testing: Monitoring short-term bacterial responses to antimicrobial agents can help reduce the time required to obtain susceptibility information.
Quantitative Measurements: Signal changes can provide quantitative information that supports the evaluation of bacterial growth and antimicrobial responses.
Potential Support for Targeted Antimicrobial Treatment: More rapid information about bacterial identity and antibiotic susceptibility may help reduce unnecessary exposure to broad-spectrum antibiotics.
10. Challenges and Considerations in Culture-Free Diagnostics
Despite their potential advantages, culture-free bacterial detection technologies also present several technical challenges.
The development of reliable diagnostic systems requires careful consideration of analytical sensitivity, specificity, reproducibility, sample complexity, and the diversity of bacterial pathogens responsible for bloodstream infections.
10.1. Low Microbial Concentrations and Biological Background
Blood is a complex biological matrix containing human cells, plasma proteins, and numerous other molecular components.
The very low concentration of bacteria in bloodstream infections makes direct detection difficult because the analytical system must distinguish bacterial targets from a much larger background of host-derived material.
This limitation is particularly relevant to molecular approaches based on direct nucleic acid detection.
10.2. Antibody Specificity
Immunological detection depends on the ability of selected antibodies to recognize specific bacterial antigens.
Differences in bacterial surface structures, antigen expression, and species composition may influence the performance of antibody-based detection.
The range of microorganisms that can be identified therefore depends on the antibody targets incorporated into the diagnostic platform.
10.3. Phenotypic Interpretation of Antibiotic Responses
Rapid AST requires sufficiently sensitive detection of bacterial responses during relatively short antibiotic exposure periods.
The system must distinguish genuine growth inhibition from variations in signal intensity associated with experimental conditions or sample composition.
The interpretation of susceptible, intermediate, and resistant categories must also be validated against appropriate reference methods and established antimicrobial susceptibility criteria.
10.4. Clinical Validation
Experimental performance does not automatically establish clinical effectiveness.
Diagnostic platforms must undergo further evaluation using appropriate clinical samples, diverse bacterial species, different infection settings, and standardized reference methods.
Clinical implementation also requires assessment of analytical reproducibility, diagnostic accuracy, workflow compatibility, and regulatory requirements.
These considerations are essential for translating promising laboratory technologies into reliable clinical diagnostic applications.
11. Clinical and Research Applications
Rapid bacterial detection and antibiotic susceptibility testing have important implications for several areas of microbiology and biomedical research.
Clinical Microbiology: Rapid identification of bloodstream pathogens can support investigations involving suspected bacterial infections and improve laboratory diagnostic workflows.
Sepsis Research: Early bacterial detection is particularly relevant to investigations of severe systemic infections where delays in pathogen identification may complicate patient management.
Antimicrobial Resistance Research: Phenotypic AST provides opportunities to study bacterial susceptibility and resistance responses to different antibiotic compounds.
Medical Device-Associated Infections: Rapid identification methods may be valuable in research involving central line-associated bloodstream infections and prosthetic valve endocarditis.
Diagnostic Technology Development: Immunoassay-based electrochemical detection platforms provide an opportunity to investigate alternative biosensor technologies for microbial detection.
Pharmaceutical and Antibiotic Research: Rapid monitoring of bacterial responses can support experimental investigations into antimicrobial activity and the evaluation of candidate antibacterial compounds.
12. Research Perspectives and Future Developments
The development of culture-free diagnostic technologies represents an important direction in modern clinical microbiology.
The combination of highly specific molecular recognition, enzymatic signal generation, and advanced electrochemical detection creates opportunities for identifying microorganisms directly from complex biological samples.
The FEED-based platform described in the original research demonstrates how intrinsic signal amplification can facilitate bacterial detection at very low concentrations while providing additional information about antimicrobial susceptibility.
Future developments in this field may focus on expanding bacterial target coverage, improving antibody recognition, increasing analytical sensitivity, and validating phenotypic AST across a wider range of microorganisms and antimicrobial agents.
Further optimization of sample preparation, measurement reproducibility, and automated interpretation may also contribute to the integration of rapid diagnostic platforms into clinical microbiology workflows.
A subsequent 2024 clinical feasibility study investigated a rapid culture-free diagnostic platform using 59 clinical blood samples. It reported preliminary diagnostic accuracies of 93.3% for bacterial detection and identification and 95.4% for antibiotic susceptibility testing, with results available at least 15 hours faster than the conventional diagnostic workflow used as a reference. These findings provide additional research evidence supporting the development of rapid phenotypic bloodstream infection diagnostics, although further validation remains necessary.
Conclusion
Rapid and accurate identification of bacterial pathogens in bloodstream infections is essential for improving microbiological diagnosis and supporting appropriate antimicrobial treatment.
Although conventional blood cultures remain an established diagnostic method, their dependence on bacterial growth and sequential identification and susceptibility testing can result in substantial delays.
Culture-free diagnostic approaches offer an alternative by combining direct bacterial recognition with highly sensitive analytical detection technologies.
The FEED-based platform described in the original research integrates antibody-mediated bacterial recognition, horseradish peroxidase enzymatic detection, and voltage-controlled signal amplification to identify bacteria directly from blood samples.
The experimental results demonstrated simultaneous bacterial detection and identification within approximately 84 minutes at concentrations below 10 CFU/mL, together with phenotypic antibiotic susceptibility testing within approximately 204 minutes.
These findings highlight the potential of integrating rapid detection technologies with functional antimicrobial response measurements.
By reducing dependence on conventional culture enrichment and accelerating the availability of microbiological information, culture-free diagnostic platforms may contribute to the development of faster and more targeted approaches for bloodstream infection diagnosis and antimicrobial resistance research.

